Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 332 | nsp3:S332L; | CL-3d;CL-3e; |
| 343 | nsp3:S343-; | CL-3e; |
| 343 | nsp3:S343A; | CL-3b; |
| 343 | nsp3:S343F; | CL-3b; |
| 370 | nsp3:S370P; | CL-3d;CL-3e; |
| 371 | nsp3:S371-; | CL-1a_3b;CL-3b;CL-3f; |
| 371 | nsp3:S371G; | CL-3b;CL-3d; |
| 371 | nsp3:S371N; | CL-3b;CL-3c; |
| 371 | nsp3:S371R; | CL-3a; |
| 377 | nsp3:S377I; | CL-3a;CL-3d;CL-3e; |
| 377 | nsp3:S377N; | CL-3e; |
| 40 | nsp3:S40-; | CL-3e; |
| 400 | nsp3:S400G; | CL-2;CL-3b; |
| 400 | nsp3:S400I; | CL-1b; |
| 400 | nsp3:S400N; | CL-3b;CL-3c; |
| 403 | nsp3:S403-; | CL-3e; |
| 454 | nsp3:S454-; | CL-3b;CL-3d;CL-3e; |
| 454 | nsp3:S454I; | CL-3b;CL-3e; |
| 454 | nsp3:S454N; | CL-1a_3c;CL-3d;CL-3e; |
| 454 | nsp3:S454R; | CL-3e; |
| 533 | nsp3:S533N; | CL-3e; |
| 540 | nsp3:S540-; | CL-3b; |
| 540 | nsp3:S540F; | CL-3e; |
| 543 | nsp3:S543-; | CL-3b; |
| 543 | nsp3:S543A; | CL-1a_3e;CL-4; |
| 554 | nsp3:S554-; | CL-3b; |
| 582 | nsp3:S582-; | CL-2;CL-3d;CL-3e; |
| 582 | nsp3:S582A; | CL-3e; |
| 582 | nsp3:S582P; | CL-3a; |
| 609 | nsp3:S609C; | CL-3b;CL-3d; |
| 609 | nsp3:S609G; | CL-3e; |
| 615 | nsp3:S615L; | CL-3d;CL-3e; |
| 650 | nsp3:S650-; | CL-3b;CL-3e;CL-3f; |
| 650 | nsp3:S650A; | CL-3c; |
| 658 | nsp3:S658T; | CL-3d; |
| 660 | nsp3:S660P; | CL-3f; |
| 661 | nsp3:S661-; | CL-3b; |
| 674 | nsp3:S674P; | CL-2; |
| 676 | nsp3:S676-; | CL-4; |
| 676 | nsp3:S676A; | CL-3e; |
| 676 | nsp3:S676F; | CL-3c;CL-3f; |
| 688 | nsp3:S688-; | CL-3e; |
| 69 | nsp3:S69-; | CL-3b;CL-3e;CL-3f; |
| 692 | nsp3:S692Y; | CL-3f; |
| 697 | nsp3:S697-; | CL-3e; |
| 699 | nsp3:S699-; | CL-3b;CL-3e;CL-3f; |
| 699 | nsp3:S699A; | CL-3b; |
| 69 | nsp3:S69F; | CL-1a_3d;CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
| 69 | nsp3:S69P; | CL-1a_3e;CL-3b; |
| 702 | nsp3:S702F; | CL-3b;CL-3c;CL-3d;CL-3e; |
Page 297 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com